Erasmus School of Health Policy & Management
Visiting fellow | Health Technology Assessment (HTA)
- hoogendoorn@eshpm.eur.nl
- Room
- J8-17
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Martine Hoogendoorn, Milanne Galekop & Pieter van Baal (2023) - The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention? - Diabetes, Obesity and Metabolism, 25 (8), 2351-2361 - doi: 10.1111/dom.15116 - [link]
- EJI (Martine) Hoogendoorn - Lips, Susan Jowett, Andrew P. Dickens, Rachel Jordan, Alexandra Enocson, Peymane Adab, MM (Matthijs) Versteegh & MPMH (Maureen) Rutten - van Molken (2021) - Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study - Value in Health, 24 (11), 1667-1675 - doi: 10.1016/j.jval.2021.05.006 - [link]
- Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, Jennifer Cook, Erkki Soini, Emma Paulsson & Maureen Rutten-Van Mölken (2021) - Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: A model-based study - BMJ Open, 11 (8) - doi: 10.1136/bmjopen-2021-049675 - [link]
- , Carola Orrego, Marta Ballester, Monique Heymans, Estela Camus, Oliver Groene, Ena Niño de Guzman, Hector Pardo-Hernandez, Rosa Sunol, Aretj Angeliki Veroniki, Carlos Canelo-Aybar, Carola Orrego, Claudia Valli, Claudio Alfonso Rocha Calderón, Cordula Wagner, Dimitri Mavridis, Ena Niño de Guzmán, Estela Camus, Gimon de Graaf, Giorgos Seitidis, Hector Pardo-Hernandez, Jany Rademakers, Jessica Beltrán, Karla Salas, Kevin Pacheco-Barrios, Kaisa Immonen, Lyudmil Ninov, Maria Petropoulou, Marieke van der Gaag, Marta Ballester, Martine Hoogendoorn-Lips, Monique Heymans, Montserrat León, Nina Adrion, Oliver Groene, Rosa Sunol, Pablo Alonso-Coello, Pieter van Baal, Rune Poortvliet, Matthijs Michaël Versteegh, Stella Zevgiti, Jessica Zafra & Valentina Strammiello (2021) - Talking the same language on patient empowerment: Development and content validation of a taxonomy of self-management interventions for chronic conditions - Health Expectations - doi: 10.1111/hex.13303 - [link]
- Isaac Corro Ramos, Martine Hoogendoorn - Lips & Maureen Rutten - van Molken (2020) - How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease - Medical Decision Making, 40, 619-632 - doi: 10.1177/0272989X20932145. - [link]
- Elly Lugtenburg, PD Brown, Ronnie van der Holt, FA D'Amore, HR Koene, E de Jongh, R Fijnheer, JW van Esser, LH Bohmer, JFM Pruijt, GE Verhoef, Martine Hoogendoorn - Lips, MY Bilgin, M Nijland, NC van der Burg-de Graauw, M Oosterveld, KS Jie, TS Larsen, MWM van der Poel, MB Leijs, MH Silbermann, MVM Kooy, A Beeker, MJ Kersten, Jeanette Doorduijn, LW Tick, RE Brouwer, King Lam, CN Burggraaff, B (Bart) de Keizer, AIJ Arens, Daniël Jong, OS Hoekstra & JM Zijlstra-Baalbergen (2020) - Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) - Journal of Clinical Oncology, 38 (29) - doi: 10.1200/jco.19.03418
- Martine Hoogendoorn - Lips, Isaac Corro Ramos, M Baldwin, N Gonzalez-Rojas Guiz & Maureen Rutten - van Molken (2019) - Broadening the perspective of cost-effectiveness modeling in COPD: a new patient-level simulation model suitable to evaluate stratified medicine. - Value in Health, 22, 313-332 - doi: 10.1016/j.jval.2018.10.008 - [link]
- S Ratushnyak, Martine Hoogendoorn - Lips & Pieter van Baal (2019) - Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained. - American Journal of Preventive Medicine, 57 (6), 792-799 - doi: 10.1016/j.amepre.2019.07.027 - [link]
- S den Boon, M Jit, M Brisson, G Medley, P Beutels, R White, S Flasche, TD Hollingsworth, T Garske, VE Pitzer, Martine Hoogendoorn - Lips, O Geffen, A Clark, J Kim & R Hutubessy (2019) - Guidelines for multi-model comparisons of the impact of infectious disease interventions - BMC Medicine, 17 (1) - doi: 10.1186/s12916-019-1403-9 - [link]
- Martine Hoogendoorn - Lips, TL Feenstra, Y Asukai, AH Briggs, RN Hansen, R Leidl, N Risebrough, Y Samyshkin, M Wacker & Maureen Rutten - van Molken (2017) - External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting - Value in Health, 20 (3), 397-403 - doi: 10.1016/j.jval.2016.10.016 - [link]
